Literature DB >> 9021938

Neural networks as predictors of outcomes in alcoholic patients with severe liver disease.

P Lapuerta1, S Rajan, M Bonacini.   

Abstract

We developed and evaluated neural networks as predictors of outcomes in alcoholic patients with severe liver disease using commonly available clinical and laboratory values. Hospital charts of 144 patients were reviewed. Nine variables (five laboratory, four clinical) were recorded along with in-hospital death or survival. Data were organized into separate development and validation sets. Neural network predictions of survival were compared with those of the Maddrey discriminant function and logistic regression models developed on the same data. Model performance was evaluated by comparing areas under receiver-operating characteristic (ROC) curves and the distributions of model scores. Survivors had significantly different laboratory and clinical characteristics, the most important being a higher prothrombin time, lower bilirubin, and lower incidence of encephalopathy. Neural network performance was significantly better than that of the Maddrey score (ROC areas, 81.5% vs. 73.8%; P = .04). The ROC area for neural networks was similar to that of logistic regression (ROC area 78.2%; P = .3), but the neural networks were more successful in classifying patients into low- and high-risk groups (P < .001). A neural network score with laboratory data from hospital-day 7 improved prognostic accuracy further to 84.3%. After adjusting for baseline risk, the neural network change in illness severity was still a significant predictor of mortality (P = .001). Neural networks using clinical and laboratory data showed a high prognostic accuracy for predicting mortality in alcoholic patients with severe liver disease.

Entities:  

Mesh:

Year:  1997        PMID: 9021938     DOI: 10.1053/jhep.1997.v25.pm0009021938

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease.

Authors:  A Cucchetti; M Vivarelli; N D Heaton; S Phillips; F Piscaglia; L Bolondi; G La Barba; M R Foxton; M Rela; J O'Grady; A D Pinna
Journal:  Gut       Date:  2006-06-29       Impact factor: 23.059

2.  Chemotherapy-induced neutropenia during adjuvant treatment for cervical cancer patients: development and validation of a prediction model.

Authors:  Kecheng Huang; Aiyue Luo; Xiong Li; Shuang Li; Shixuan Wang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Models for prediction of mortality from cirrhosis with special reference to artificial neural network: a critical review.

Authors:  Uday Chand Ghoshal; Ananya Das
Journal:  Hepatol Int       Date:  2007-11-27       Impact factor: 6.047

4.  Added value of a resting ECG neural network that predicts cardiovascular mortality.

Authors:  Marco V Perez; Frederick E Dewey; Swee Y Tan; Jonathan Myers; Victor F Froelicher
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

5.  Pretransplant prediction of posttransplant survival for liver recipients with benign end-stage liver diseases: a nonlinear model.

Authors:  Ming Zhang; Fei Yin; Bo Chen; You Ping Li; Lu Nan Yan; Tian Fu Wen; Bo Li
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.